FirstWord Pharma
VerifiedOnline/Digital
FirstWord Pharma supplies global news and intelligence to the pharmaceutical industry. The service provides the top industry news stories on a daily basis in a format that is quick and easy to access so that users can always be in-the-know about the latest news and developments in their industry. Source
Actions
Media Outlet details
| Scope | International, Trade/B2B |
|---|---|
| Language | English |
| Country | United States of America |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
Recent Articles
Search ArticlesFirstWord Pharma
Opens an external website in a new window This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, and marketing. To learn more, view the following link: Cookie Policy Something went wrong! Please refresh the page and try again. Something went wrong! Please refresh the page and try again. Error loading the articles: Cannot destructure property 'config' of 'n' as it is undefined.
Celcuity shares fall as delayed breast cancer drug launch eclipses first US FDA approval
Many companies have an IEGP. Fewer have one that truly aligns evidence generation with stakeholder decision-making and product success.
Rakovina Therapeutics Announces $1.5 Million Private Placement
VANCOUVER, British Columbia, July 15, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV)( FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, today announces a non-brokered private placement offering (the “Offering”) of up to $1.5 million.